[Clinical analysis of blood ammonia levels for predicting survival following transjugular intrahepatic portosystemic shunt in patients with cirrhosis]

[临床分析血氨水平对肝硬化患者经颈静脉肝内门体分流术后生存率的预测价值]

阅读:1

Abstract

Objective: To assess the blood ammonia levels value for predicting survival following transjugular intrahepatic portosystemic shunt (TIPS) therapy in patients with cirrhosis. Methods: Data from 236 cirrhotic patients who underwent TIPS treatment at Nanjing Drum Tower Hospital from March 2018 to January 2020 were retrospectively collected. Data included patients' blood routine, liver and kidney function, coagulation function tests, hepatic encephalopathy status, and etiology leading to TIPS treatment at the initial admission. The Child-Turcotte-Pugh (CTP) score and the Model for End-Stage Liver Disease (MELD) score were concurrently calculated for patients' liver function. Patients were grouped into a high AMM-ULN group and a low AMM-ULN group based on the criterion of 1.4 times the upper limit of normal for calibrated ammonia levels (AMM-ULN). Postoperative follow-up information such as rebleeding of the upper gastrointestinal tract, ascites, hepatic encephalopathy, and survival-related outcomes was collected for analysis. Measurement data that did not conform to a non-normal distribution were compared using the Mann-Whitney U test. Categorical data were compared using the χ(2) test between the groups. Kaplan-Meier survival curves were used to plot survival rate. Cox regression models were used for univariate and multivariate analysis. Results: AMM-ULN, CTP score, and ascites were independent risk factors affecting the liver function in surviving patients with cirrhosis following TIPS (P<0.05). The 3-year survival rates for the high and low AMM-ULN groups were 66.3% and 92.4%, respectively, showing a significant statistical difference (P<0.001) in terms of survival rate. AMM-ULN was superior in terms of predicting 3-year survival rates (0.850 vs. 0.598, P<0.05) compared to the CTP score and had no significant difference compared to the MELD score models in accordance with the receiver operating characteristic curves. Conclusion: AMM-ULN is an independent predictor for cirrhotic patients who have survived following TIPS and has certain advantages in terms of predicting survival rates.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。